Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

To What Extent Are Cryopreserved Sperm and Testicular Biopsy Samples Used in Assisted Reproduction?

Author
Department of Gynaecology and Obstetrics, Ulm University, Ulm, Germany
Abstract
Background: Testicular biopsies and ejaculated spermatozoa are routinely cryo-preserved in many units but the fate of these samples has not provoked large interest. This prompted us to review our data accumulated during a period of 20 years (1997 to 2016). Methods: For patients with biopsies (group 1) or ejaculated spermatozoa (group 2), an attempt was made to evaluate whether the samples stored, had been discarded with the patient’s consent or because the patient had died, or whether they had been transported to another laboratory. In each of these categories, a previous use in our program of assisted reproduction was assessed. Results: The total utilization rate in group 1 (n=95) was 53.7% and only 5.48% in group 2 (n=365). In both groups, deceased patients had not previously used their cryopreserved samples. In detail, the utilization rates for still banked, discarded and transferred samples were 84.2%, 50% and 27.3%, respectively in group 1 and 2.88%, 10.4% and 10%, respectively in group 2. Conclusion: The exact reasons for the low utilization rates of cryopreserved male gametes remain to be explored. A closer contact between sperm banking units and patients might be useful to discuss the need for further storage of the probes, their possible disposal or the prospects when a specific use for assisted reproduction is intended.
Keywords

  1. Meirow D, Schenker JG. Cancer and male infertility. Hum Reprod. 1995;10(8):2017-22.
  2. Pacey AA, Eiser C. Banking sperm is only the first of many decisions for men: What healthcare professionals and men need to know. Hum Fertil (Camb). 2011;14(4):208-17.
  3. Tomlinson M, Meadows J, Kohut T, Haoula Z, Naeem A, Pooley K, et al. Review and follow-up of patients using a regional sperm cryopreservarion service: ensuring that resources are targeted to those patients most in need. Andrology. 2015;3(4):709-16.
  4. Sanger WG, Olson JH, Sherman JK. Semen cryobanking for men with cancer--criteria change. Fertil Steril. 1992;58(5):1024-7.
  5. Lass A, Akagbosu F, Abusheikha N, Hassouneh M, Blayney M, Avery S, et al. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years’ experience. Hum Reprod. 1998;13(11):3256-61.
  6. Sadeghi MR. It is time to pay more attention to sperm cryopreservation: now more than ever! J Reprod Infertil. 2016;17(1):1.
  7. Zhang QF, Qiao J, Bai Q, Li M, Lian Y, Wu YQ, et al. [Outcome of intracytoplasmic sperm injection cycle: fresh compared to cryopreserved-thawed testicular and epididymal spermatozoa]. Zhonghua Fu Chan Ke Za Zhi. 2009;44(10):740-4. Chinese.
  8. Botchan A, Karpol S, Lehavi O, Paz G, Kleiman SE, Yogev L, et al. Preservation of sperm of cancer patients: extent of use and pregnancy outcome in a tertiary infertility center. Asian J Androl. 2013;15(3):382-6.
  9. Záková J, Lousová E, Ventruba P, Crha I, Pochopová H, Vinklárková J, et al. Sperm cryopreservation before testicular cancer treatment and its subsequent utilization for the treatment of infertility. ScientificWorldJournal. 2014;2014:575978.
  10. Ferrari S, Paffoni A, Filippi F, Busnelli A, Vegetti W, Somigliana E. Sperm cryopreservation and reproductive outcome in male cancer patients: a systematic review. Reprod Biomed Online. 2016;33(1):29-38.
  11. Ragni G, Somigliana E, Restelli L, Salvi R, Arnoldi M, Paffoni A. Sperm banking and rate of assisted reproduction treatment. Cancer. 2003;97(7):1624-9.
  12. Kelleher S, Wishart SM, Liu PY, Turner L, Di Pierro I, Conway AJ, et al. Long-term outcomes of elective human sperm cryostorage. Hum Reprod. 2001;16(12):2632-9.